Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study
- 1 December 2021
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (7), 1335-1342
- https://doi.org/10.1002/ccd.29371
Abstract
Aims The aim of SiBi study was to evaluate the early vascular healing and neointimal coverage after implantation of ultrathin (60 mu m) biodegradable polymer-coated Tetriflex (Sahajanand Medical Technologies Pvt. Ltd., Surat, India) sirolimus-eluting stent (SES) using optical coherence tomography (OCT) at 4 to 6 weeks after implantation. Methods SiBi was a single-center, observational, investigator-initiated study. From January 15, 2018 to April 15, 2018, total 29 consecutive patients who had consented and underwent OCT examination at 4-6 weeks after Tetriflex SES implantation were enrolled. All OCT images were analyzed at an independent core laboratory by analysts who were blinded to patient and procedural information. Results Of 29 patients, four patients were excluded, as those OCT images were technically inadequate for analysis. Therefore, 25 patients were included in final OCT analysis. Average OCT analysis was performed after 35.3 +/- 5 days of Tetriflex implantation. Total 14,024 stent struts in 1,520 cross sections were analyzed. Strut tissue coverage was observed in 91.26 +/- 5.53% of struts and malapposed struts were seen in 0.89 +/- 1.67%. The mean neointimal hyperplasia (NIH) thickness on the covered struts was 50 +/- 30 mu m. Conclusion A large percentage of struts were found to be covered with thin layer of NIH evenly distributed along the stent length at around 1 month from stent implantation. The results of this pilot study serve as ethical and scientific backbone to conduct an adequately powered clinical trial to evaluate outcomes of short dual-antiplatelet therapy in context of ultrathin strut stent.This publication has 29 references indexed in Scilit:
- Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months’ follow-up: an optical coherence tomography studyHeart and Vessels, 2014
- Two‐week interval optical coherence tomography: Imaging evidence on neointimal coverage completion after implantation of the endeavor zotarolimus‐eluting stentCatheterization and Cardiovascular Interventions, 2013
- Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomographyHeart and Vessels, 2013
- A New Strategy for Discontinuation of Dual Antiplatelet TherapyJournal of the American College of Cardiology, 2012
- Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional proceduresEuropean Heart Journal, 2012
- Consensus Standards for Acquisition, Measurement, and Reporting of Intravascular Optical Coherence Tomography Studies: A Report From the International Working Group for Intravascular Optical Coherence Tomography Standardization and ValidationJournal of the American College of Cardiology, 2012
- Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trialEuropean Heart Journal, 2011
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug CoatingsCirculation, 2011
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2008
- Pathological Correlates of Late Drug-Eluting Stent ThrombosisCirculation, 2007